ArticleCurrent drug targets2026

Rationally Engineered Small Molecules: Pharmacophore Modeling and Molecular Docking Studies Targeting Toxic Polyglutamine (PolyQ) Repeats in Huntington's Disease.

Jangampalli Adi Pradeepkiran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.